New York, NY -- (SBWIRE) -- 10/22/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Symmetricom, Inc. (NASDAQ:SYMM), Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), China New Borun Corp (NYSE:BORN), Depomed Inc (NASDAQ:DEPO)
Symmetricom, Inc. (NASDAQ:SYMM) is flying high in the current trading session following the news that Microsemi Corp. has decided to acquire Symmetricom for nearly $298 million. Symmetricom will receive $7.18 per share that indicates a hefty premium of 51 percent from the stock’s closing price yesterday. SYMM stock has a 52-week range of $4.34 to $7.23. The company has a market capitalization of $296.89 million.
What was the Moving Force behind SYMM on Bullish Run? Read This Research Report on SYMM
Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) jumped 48.57 percent to $2.08 today on traded volume of 3.90 million shares after the company said that it has inked a deal to purchase certain assets of a privately-held biopharmaceutical firm, Phyxius Pharma. OXBT stock has a 52-week range of $1.19 to $22. The company has a market capitalization of $10.51 million.
Will OXBT Continue To Move Higher? Find Out Here
China New Borun Corp (NYSE:BORN) jumped 13.64 percent to $2.50 in the mid-day trading session today. The stock has a 52-week range of $1.05 to $4.40. BORN shares have been soaring from the last few days. The stock climbed nearly 74 percent in the past five days. The company has a market capitalization of $60.45 million and P/E ratio of 3.89.
Why Should Investors Buy BORN After The Recent Gain? Just Go Here and Find Out
Depomed Inc (NASDAQ:DEPO) rose 8.45 percent to $7.84 today on traded volume of 1.55 million shares. The stock has a 52-week range of $4.99 to $8.05. Depomed is a specialty pharmaceutical firm primarily focused on pain, neurology and other disorders related to the central nervous system. Its product includes Glumetza, Gralise, Serada and DM-1992. The company has a market capitalization of $445.06 million.
What DEPO’s Charts Are Signaling for Traders? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)